LEO 29102 cream

DRUG3 trials

Sponsors

LEO Pharma

Conditions

Atopic DermatitisPsoriasis Vulgaris

Phase 1

Assessment of the Phototoxic Potential of LEO 29102 Cream

CompletedNCT00958516

LEO PharmaAtopic Dermatitis

Start: 2009-09-30End: 2009-10-31Updated: 2025-02-24

A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis

CompletedNCT01005823

LEO PharmaAtopic Dermatitis

Start: 2009-10-31End: 2010-05-31Updated: 2025-02-24

Phase 2

A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products

CompletedNCT00875277

LEO PharmaPsoriasis Vulgaris

Start: 2009-04-30End: 2009-07-31Updated: 2025-03-12